InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has made significant strides in its pharmaceutical programs, ...

Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...

A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

"Popeyes of Laredo is always looking to give back to the community and sees the need for Alzheimer’s awareness and support," ...

"Many studies have shown that the accumulation of tau in neurons and glial cells in the brain is a main characteristic of Alzheimer's disease and at least 24 more neurological diseases," said first ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients ...

Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the value of ultra-low-field MRI in monitoring amyloid-related imaging abnormalities (ARIA).

Sandra Demontigny was afraid of being a prisoner in her own body: a 45-year-old diagnosed with early-onset Alzheimer's, she worried about losing control of her life and burdening those she loves ...

Hallucinations are a fairly common symptom in the advanced stages of Alzheimer’s disease. Treatment options like medications or therapy can help reduce their frequency and effect. Alzheimer’s ...

Alzheimer’s disease may cause cognitive complications like severe memory loss, mental health complications like depression, and physical complications like reduced mobility. Alzheimer’s ...